GGrantIndex
← Leaderboards

Christoph U Correll

Feinstein Institute For Medical Research

$3,918,408
Attributed
$3,918,408
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $923.9K · FY200514
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14

Funding mix

By agency

NIH$3,918,408 · 11

By mechanism

R01$1,652,840 · 2
M01$1,392,138 · 6
P30$873,430 · 3

Top collaborators

No co-investigators on record.

Most similar at Feinstein Institute For Medical Research

Same institution · by research overlap

Others in their field

Top investigators on “Antipsychotic Agents

Research focus

Antipsychotic AgentsPharmaceutical PreparationsSchizophreniaAdverse EffectsRelapseSymptomsPrevalenceAripiprazoleLeadGenerationsAdolescentPsychotic DisordersAdverse EventMetabolicAdherence (Attribute)RandomizedClinical ResearchAreaChronicIncidenceFunctional OutcomesPlacebosEffectivenessDesign

Grant awards (30)

Adverse Events Unit (Research Methods Core)$57,538
P30 · FY2014 · MH · contact PI
Project 4 ACISR$49,010
P30 · FY2014 · MH · contact PI
Project 1 ACISR$45,840
P30 · FY2014 · MH · contact PI
Adverse Events Unit (Research Methods Core)$58,844
P30 · FY2013 · MH · contact PI
Project 4 ACISR$50,894
P30 · FY2013 · MH · contact PI
Project 1 ACISR$47,942
P30 · FY2013 · MH · contact PI
3/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$322,106
R01 · FY2012 · MH · contact PI
Adverse Events Unit (Research Methods Core)$56,125
P30 · FY2012 · MH · contact PI
Project 4 ACISR$48,083
P30 · FY2012 · MH · contact PI
Project 1 ACISR$45,097
P30 · FY2012 · MH · contact PI
Project 1 ACISR$18,320
P30 · FY2012 · MH · contact PI
Adverse Events Unit (Research Methods Core)$18,320
P30 · FY2012 · MH · contact PI
Project 4 ACISR$18,318
P30 · FY2012 · MH · contact PI
3/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$271,161
R01 · FY2011 · MH · contact PI
Project 1 ACISR$77,395
P30 · FY2011 · MH · contact PI
Adverse Events Unit (Research Methods Core)$55,459
P30 · FY2011 · MH · contact PI
Project 4 ACISR$47,652
P30 · FY2011 · MH · contact PI
FACTORS FOR METABOLIC ABNORMALITIES IN CHILDREN WITH PSYCHIATRIC DISORDERS$81,393
M01 · FY2010 · RR · contact PI
Project 1 ACISR$76,576
P30 · FY2010 · MH · contact PI
Adverse Events Unit (Research Methods Core)$54,871
P30 · FY2010 · MH · contact PI
Project 4 ACISR$47,146
P30 · FY2010 · MH · contact PI
IMPROVING METABOLIC PARAMETERS OF ANTIPSYCHOTIC CHILD TREATMENT (IMPACT)$6,359
M01 · FY2010 · RR · contact PI
3/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$1
R01 · FY2010 · MH · contact PI
3/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$365,200
R01 · FY2009 · MH · contact PI
3/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$364,650
R01 · FY2008 · MH · contact PI
BIOLOGICAL AND GENETIC RISK FACTORS FOR WEIGHT GAIN AND METABOLIC ABNORMALITIES$21,179
M01 · FY2008 · RR · contact PI
BIOLOGICAL AND GENETIC RISK FACTORS FOR WEIGHT GAIN AND METABOLIC ABNORMALITIES$160,203
M01 · FY2007 · RR · contact PI
BIOLOGICAL & GENETIC RISK FACTORS FOR ANTI-PSYCHOTIC INDUCED WEIGHT GAIN & ME$528,790
M01 · FY2006 · RR · contact PI
BIOLOGICAL &GENETIC RISK FACTORS FOR ANTI-PSYCHOTIC INDUCED WEIGHT GAIN &ME$594,214
M01 · FY2005 · RR
Treating Refractory Childhood Schizophrenia$329,722
R01 · FY2005 · MH